As per Data Bridge Market Research Analysis the global antifibrinolytic market size was valued at USD 18.23 billion in 2025 and is expected to reach USD 26.93 billion by 2033, at a CAGR of 5.00% during the forecast period
The market growth is largely driven by the increasing prevalence of surgical procedures, trauma cases, and chronic conditions such as cardiovascular diseases and bleeding disorders, which necessitate effective blood loss management and hemostatic control
Furthermore, rising demand for cost-effective and efficient therapies in perioperative care, along with growing awareness regarding patient blood management (PBM) strategies across hospitals and healthcare systems, is positioning antifibrinolytic agents as essential components in modern clinical practice. These combined factors are significantly accelerating the adoption of antifibrinolytic therapies, thereby boosting overall market growth
